This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
LifeSpan Biosciences
product type :
antibody
product name :
OPRM1 / Mu Opioid Receptor Antibody (aa384-398) LS-C17020
catalog :
LS-C17020
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot, immunohistochemistry, immunocytochemistry, immunohistochemistry - frozen section
product information
AntibodyID :
17761
AntibodyName :
LS-C17020
TargetSpecies :
Human
Host Species :
Rabbit
Product Name :
OPRM1 / Mu Opioid Receptor Antibody (aa384-398) LS-C17020
Specificity :
Mu opioid receptor, C-terminal domain. Specificity confirmed by immunodot-blot assay. No reactivity to the N-terminus, second extracellular loop or a different segment of the carboxy tail of the mu opioid receptor. No reactivity to either the delta or kappa opioid receptor. Species cross-reactivity: Human, rat and mouse.
ClonalityDesc :
Polyclonal
AntibodyModification :
Unconjugated
AntigenModification :
aa384-398
PresentationDesc :
0.09% Sodium Azide
ImmunogenType :
Synthetic peptide
ImmunogenDesc :
Synthetic peptide corresponding to aa384-398 (NHQLENLEAETAPLP) from the C-Terminus of cloned rat mu opioid receptor-1 (bovine thyroglobulin coupled by glutaraldehyde). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Monkey, Marmoset, Mouse, Rat, Horse, Pig, Opossum (100%); Bovine, Dog, Rabbit, Platypus (93%); Turkey, Chicken (80%).
PurificationDesc :
Antiserum
RecommendedStorageDesc :
Short term: store at 4°C. Long term: store at -20°C. Avoid freeze-thaw cycles.
IsotypeName :
IgG
Gene :
OPRM1 / Mu Opioid Receptor
StandardGeneSymbol :
OPRM1
gene family :
GPCR
Subfamily :
Opioid
Reactivity :
Mouse, Rat, Pig, Horse, Human, Monkey
Usage :
IF, IHC, IHC-Fr, WB
ShortWebDescription :
Mu Opioid Receptor antibody LS-C17020 is an unconjugated rabbit polyclonal antibody to Mu Opioid Receptor (OPRM1) (aa384-398) from human. It is reactive with human, mouse, rat and other species. Validated for IF, IHC and WB.
UsageText :
Suitable for use in Immunofluorescence, Immunohistochemistry, and Western Blot. Immunohistochemistry: 1:500-1:1000 (Cy3 technique); 1:6000-1:10000 (Biotin/avidin-HRP technique). Dilute antibody in PBS, 0.3% Triton X-100. Incubate 18-24 hrs at 2-8?C. Perfusion Fixation: With 500 ml 0.1 M phosphate buffer, pH 7.4, 4% paraformaldehyde for 20-30 minutes. Post Fixation: 0.1 M phosphate buffer, pH 7.4, 4% paraformaldehyde for 1.5 hours at 4?C. Sections: 10um cryostat. Note that a change in the fixation or buffering system as used in our protocol may change the configuration of the protein, and therefore, may alter the reactivity with the tissue tested. Pre-adsorption with immunogen peptide at 10 ug/ml completely eliminates labeling.
Synonyms :
OPRM1, M-OR-1, LMOR, MOR, Mu-type opioid receptor, HMOP, Opioid mu receptor, MOP, MOR-1, MOR1, Mu opioid receptor, Opioid receptor, mu 1, KIAA0403, MOR-1C, Mu opiate receptor, Mu opioid receptor hMOR-1a, Opioid mu-type receptor, OPRM
SalesRegion :
Worldwide
company information
LifeSpan Biosciences
2401 Fourth Avenue, Suite 900
Seattle, WA 98121
Seattle, WA 98121
CustomerSupport@lsbio.com
https://www.lsbio.com1-206-464-1554
headquarters: USA
Since 1995, LifeSpan has been the industry leader in molecular pathology, specializing in the localization of proteins in normal and diseased tissues, both human and non-human. We offer more than 74,000 antibodies, custom designed immunohistochemistry (IHC) studies, immediately available human tissue IHC profiles for more than 500 proteins, and histology and pathology services. Our bank of 2 million specimens is available to support our customers' contract research studies and contains frozen and formalin-fixed (FFPE) normal and diseased tissues. Our contract services are comprehensive; they include study design, antibody sourcing and characterization, tissue sourcing and validation, immunolabeling, trouble shooting, and interpretation of the results by a LifeSpan pathologist.
questions and comments